ALLO — Allogene Therapeutics, Inc. | XLV Holdings | StockAdder

(ALLO)

Allogene Therapeutics, Inc.

Live chart and latest ALLO stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

ALLO News

Biotech Allogene sells 87.5M shares at $2 to raise $175M

Apr 15, 2026 Yahoo Finance

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Apr 15, 2026 Quiver Quantitative

Allogene Therapeutics, Inc. Prices Public Offering of 87.5 Million Shares at $2.00 per Share

Apr 15, 2026 Bitget

Allogene Therapeutics Announces Pricing of Public Offering of Common Stock

Apr 15, 2026 Investing.com

Allogene prices $175 million stock offering at $2 per share

Apr 15, 2026 TIKR.com

Allogene Therapeutics Stock Soars 12% On Positive Phase 2 Data For Lymphoma Treatment

Apr 14, 2026 marketscreener.com

Allogene Therapeutics announces pricing of public offering of common stock

Apr 15, 2026 TipRanks

Allogene Therapeutics Launches New Underwritten Common Stock Offering

Apr 13, 2026 TradingView — Track All Markets

ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study

Apr 14, 2026 GuruFocus

Allogene Therapeutics (ALLO) Plans $175M Stock Offering

Apr 14, 2026 Yahoo Finance

Why Do Analysts See 180%+ Upside for Allogene Therapeutics (ALLO)?

Apr 12, 2026 Stock Titan

If You Invested $1,000 in Allogene Therapeutics (ALLO)

Apr 12, 2026 Investing.com

Bernstein raises Allogene stock price target on trial data

Apr 14, 2026 Bitget

Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock

Apr 14, 2026 Investing.com

Citizens raises Allogene stock price target on trial data strength